Cancer in Korean patients with end-stage renal disease: A 7-year follow-up
Kyung Don Yoo(Ulsan College), Chun Soo Lim(Seoul National University), Jung Pyo Lee(Seoul National University), Dong Ki Kim(Seoul National University), Su Mi Lee(Dong-A University), Kwon Wook Joo(Seoul National University), Hajeong Lee(Seoul National University), Chul Woo Yang(Yunnan University), Yong-Lim Kim(Kyungpook National University Hospital), Jae Yoon Park(Dongguk University Ilsan Hospital), Shin‐Wook Kang(Yonsei University), Yon Su Kim(Seoul National University)
Cited by 25
Related Papers
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2019|425
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
|Nephrology Dialysis Transplantation|2020|189
Circulating α-Klotho Levels in CKD and Relationship to Progression
|American Journal of Kidney Diseases|2013|184